Rare diseases
Investigational molecules
Locations
Back to Hungary19 clinical trials in Komarom, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
HungaryStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
HungaryStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
HungaryA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
HungaryA Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity
HungaryA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
HungaryStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
HungaryStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
HungaryStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
HungaryStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
HungaryStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
HungaryEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
HungaryThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on atherosclerotic cardiovascular disease prevention and innovative treatments for atrial fibrillation. Research aims to evaluate new therapeutic approaches for stroke prevention and cardiac event reduction.
Multiple trials comparing the effectiveness of novel medications against established treatments for heart conditions.
Clinical research examining treatments for Type 2 Diabetes Mellitus and mixed dyslipidemia. Studies evaluate new therapeutic agents aimed at improving metabolic health outcomes.
Innovative approaches being tested to address complex metabolic conditions and their complications.
Advanced research into treating Chronic Obstructive Pulmonary Disease, particularly focusing on patients with frequent exacerbations. Studies evaluate targeted biological therapies for respiratory conditions.
Trials specifically designed to address severe respiratory conditions and improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
